Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Diagenode and Alithea Genomics collaborate to offer scalable and affordable RNA-seq services


Diagenode, a leading global provider of solutions for epigenetics research and sample preparation, has partnered with Alithea Genomics to provide a novel low cost, high performance 3’ mRNA-seq service to help advance transcriptomics research.

The new Alithea-powered technology, known as “MERCURIUS”, enables reliable gene expression quantification across the transcriptome with accurate differential analysis. The technology is highly scalable for large investigational studies, allowing the assessment of multiple conditions of interest or increasing statistical power underlying differential expression analysis with larger sets of replicates. The innovative barcoding approach supporting the new service makes the analysis of large cohorts of samples robust and cost efficient.

Diagenode brings deep expertise to commercializing this service for RNA researchers to help them to gain insight into processes such as cellular differentiation, carcinogenesis, transcription regulation and biomarker discovery among others. In addition to the company’s long history in developing advanced technologies for epigenomics services across DNA, RNA, and chromatin, Diagenode recently launched a unique D-Plex small RNA-seq library preparation solution for low inputs and high diversity as well as a bioinformatics data mining services – which addresses the challenge of analyzing RNA-seq data by applying machine learning, statistics, and database systems.

“The new Diagenode high-throughput 3’mRNA-seq service provides an excellent solution to identify genes that are differentially expressed in distinct cell populations, or in response to different treatments,” said Caroline Quoilin, Product Manager at Diagenode. “This service allows for the processing of a large number of samples simultaneously and will help researchers to investigate cell development mechanisms, to determine the molecular dysregulation that causes cancer and other diseases, and to study drug mode of action.”

Caroline Quoilin expanded, “We are committed to expanding our services to make RNA research optimal and accessible for labs of any size and budget.”

“We strongly believe that the combination of Diagenode’s outreach and Alithea’s technology will translate into a successful partnership,” said Riccardo Dainese, CEO of Alithea Genomics. “This partnership will enable us to reliably and efficiently provide the benefits of the MERCURIUS technology on a large scale, for the benefits of its final users, who will finally have at their disposal a high-quality yet cost-efficient RNA sequencing solution.”

To learn more about Diagenode’s services, please visit: https://www.diagenode.com/en/p/high-throughput-3mrna-seq-services

About Alithea Genomics S.A:

Alithea Genomics is a young Swiss startup that recently spun off of the Swiss Institute of Technology (EPFL) in Lausanne. Alithea develops solutions of high-throughput bulk transcriptomics based on its proprietary technology called MERCURIUS. For more information about Alithea Genomics, please visit the company’s website at http://www.alitheagenomics.com.

About Diagenode:

Diagenode is a leading provider of complete solutions for epigenetic research and epigenomics services. The company has developed a comprehensive approach to gain new insights into epigenetic studies, offering innovative shearing and automation instruments, reagent kits, and high quality antibodies to streamline DNA methylation, non coding RNA-seq, ChIP, and ChIP-seq workflows. The company’s latest innovations include a unique, full automation system, a Reduced Representation Bisulfite Sequencing (RRBS) Kit providing eight times more coverage than standard technologies, ChIPmentation and ChIP-seq kits for only 10,000 cells, and the industry’s most validated antibodies. For more information about Diagenode, please visit the company’s website at http://www.diagenode.com.

Share article on social media or email:

Workit Health’s Tele-MAT Digital Addiction Treatment Joins Horizon’s Network


Workit Health’s telemedicine program offering evidence-based digital treatment for opioid and alcohol use disorders will be covered under all Horizon Commercial, Medicare and Medicaid plans.

Workit Health today announced the expansion of its health care service to include Horizon Healthcare Services, Inc., New Jersey’s oldest and largest health insurer. Workit Health’s telemedicine program offering evidence-based digital treatment for opioid and alcohol use disorders will be covered under all Horizon Commercial, Medicare and Medicaid plans.

Horizon members are now able to sign up for Workit Health’s digital addiction care online or over the phone without a referral, and clinicians in primary care and emergency department settings are able to refer those who need care electronically. Treatment is provided via Workit Health’s web and phone apps, and includes therapy from licensed counselors, medication management with buprenorphine/naloxone or naltrexone, and a personalized curriculum of evidence-based interactive courses.

“We know people using buprenorphine are twice as likely to stay in treatment — we’ve seen its efficacy reflected in our outcomes, with our adherence rates beating those of traditional treatment by 60 percent, for one-tenth of the cost,” said Workit Health’s Co-CEO, Lisa McLaughlin. “Innovative health plans can lead the way to making buprenorphine more available, and we applaud partners like Horizon for prioritizing the overdose crisis and its members with substance use disorders,” McLaughlin said.

“As people in recovery ourselves, Lisa and I understand how the recovery support system can fail,” said Robin McIntosh, Workit Health’s Co-CEO. “We’ve lost many loved ones to overdose, and we’re committed to reaching the 90 percent of people struggling with addiction who currently are not receiving the help they need. We’re looking forward to providing Horizon members with access to evidence-based and judgment-free care, while reducing costs for everyone.”

Despite buprenorphine/naloxone being the gold-standard FDA-approved medication to treat opioid use disorder, only one-quarter of addiction treatment providers in New Jersey offer the medication. Horizon members struggling with opioid use disorder will now be able to receive ongoing buprenorphine/naloxone treatment on their phones, seeing expert clinicians via video through Workit’s app. The digital program also includes 24/7 messaging with their care team, online recovery groups, and clinically-verified drug testing, and therapeutic interactive courses reviewed by licensed counselors. Currently Workit Health has a clinic location in Hamilton Township, Mercer County, but care is 100% virtual due to COVID-19.

Horizon members struggling with alcohol use disorder can safely detox at home with daily clinical care and medication management via the Workit Health app. Workit’s alcohol program offers multiple options for recovery, including a moderation option that utilizes naltrexone with the Sinclair Method, or an abstinence option with naltrexone or Vivitrol. Workit Health practices a harm reduction philosophy in which members aren’t punished for substance use and are able to choose what behavior they’d like to change, and when.

“The shelter in place environment from COVID-19 has dramatically heightened the need to bring telehealth options to our members who battle every day on their journey to recovery from a substance use disorder – it’s unfortunately the perfect storm which requires tremendous support in the recovery community and easily accessible telehealth treatment solutions,” said Suzanne Kunis, Horizon’s Vice-President of Behavioral Health. “The Workit telemedicine platform makes it possible for New Jersey-licensed physicians, clinicians, therapists and certified coaches, at no cost to the Horizon member during the COVID-19 Pandemic, to assess the unique needs of each member and to tailor solutions that will support their journey to recovery from their own home. Workit offers a comprehensive, holistic approach to Medication Assisted Treatment including prescribing FDA approved medications with concomitant therapy and peer support utilizing phones, laptops, tablets and other smart devices. Workit is a great addition to Horizon’s network and we are honored to work with their team.”

While nearly eight New Jersey residents die from drug overdoses each day, New Jerseyians have often relied upon high-cost, out-of-state treatment programs which may not offer medication. Medications like buprenorphine have been proven to cut death rates from overdose in half and increase the likelihood of long-term recovery. Workit Health was created as a direct response to this crisis by two experienced founders in long-term recovery, and has been working with national clinical experts and organizations since its foundation, including Itai Danovitch, MD, the Commissioner of California’s Mental Health Services Oversight and Accountability Commission. Both the National Science Foundation and the National Institute on Drug Abuse have awarded Workit Health grants for their innovative offerings.

About Workit Health

Workit Health is a Joint Commission-accredited B-Corporation offering online, on-demand evidence-based addiction treatment including telemedicine medication for opioid use disorder. We partner with healthcare organizations to deliver an innovative digital health solution that blends the best of human-centered design, technology, and science. Through our mobile and web apps, members meet with clinicians and counselors, join recovery groups, and complete self-set recovery goals. Our interactive curriculum of online courses keep members on track in the comfort of home. We offer 24/7 recovery that fits into daily life, designed by experts. For more information, visit http://www.workithealth.com.

Share article on social media or email:

Periodontists in Bradenton and Lakewood Ranch, FL Celebrate 40 Years of Honest, High-Quality Periodontal and Dental Implant Care


Periodontists in Bradenton and Lakewood Ranch, FL, Drs. Justin Craighead, Lindsay Eastman, and Christie Eastman-Craighead

Eastman Periodontics and Implants Celebrates Four Decades in Practice

I was looking for quality, but I got more than that. I got quality, honesty, and integrity.

The Eastman Periodontics and Implants team has now been providing high-quality and trusted periodontal care for 40 years. Esteemed periodontists, Drs. Lindsay Eastman, Christie Eastman-Craighead, and Justin Craighead have been honored to serve their community and look forward to not only continuing to offer honest periodontal care, but further their field with innovative techniques and minimally invasive alternatives.

“I was looking for quality, but I got more than that. I got quality, honesty, and integrity,” says a long-time patient of Dr. Eastman. According to many, this practice offers an experience unlike many others; a personal one.

Dr. Lindsay Eastman founded Lindsay B. Eastman, DDS, MS, PA in Bradenton, Florida in 1980. A periodontal specialist, he was already qualified to offer expert gum disease treatment, soft tissue grafting, and dental implant surgery, among other treatments. A life-long learner, he continues to expand his skillset with the latest techniques to ensure his patients receive the highest quality services that minimize pain, reduce healing times, and maximize the effectiveness of treatment.

As a result, he was not only one of the first in the United States to be trained in computer-guided dental implant surgery, which takes the guesswork out of implant placement, but one of the first in his area to offer LANAP®, the only FDA-cleared laser periodontal disease technique. Beyond what was taught to him, Dr. Eastman combined his training and certifications with practical experience to develop his own less invasive techniques including a unique approach to gum grafting that drastically reduces patients’ pain.

Over the last 40 years, Dr. Eastman and his team have made significant advancements in their technology, their team, and their treatments. The PerioLase® MVP-7™ dental laser, cone beam CT scanner, OralDNA® tests, Piezosurgery®, and plasma rich growth factors all play their part in a transformational and comfortable treatment experience at Eastman Periodontics and Implants.

In 2014 Dr. Eastman opened his second practice, Eastman Periodontics and Implants, in Lakewood Ranch, FL before two new periodontists, his daughter and son-in-law Drs. Christie Eastman-Craighead and Justin Craighead, joined the practice in 2016. In fact, Dr. Craighead is one of the only dual specialists in periodontics and prosthodontics in the state of Florida. Together this team of educators and distinguished periodontists has performed thousands of successful gum disease treatments, dental implant placements, and tooth extractions.

A family practice, Dr. Eastman’s team continues to provide the same patient-centered values that he founded the practice on. As Dr. Eastman stated, “We will go above and beyond to make sure our patients are cared for. That’s what I’m passionate about, coming to work and saying, ‘let’s make it a great day by changing a patient’s life.’”

Those interested in receiving high-quality periodontal care from a team of respected periodontists can schedule a personalized appointment at either of their two locations in Bradenton or Lakewood Ranch, FL. More information on the treatments they offer or the technology they use can be found on their website at http://www.eastmanonline.com.

About the Periodontists

Eastman Periodontics and Implants was founded by Dr. Lindsay Eastman in 1980. Now with two locations in Bradenton and Lakewood Ranch, FL, Dr. Eastman also has two associates, his daughter Dr. Christie Eastman-Craighead and his son-in-law Dr. Justin Craighead. Dr. Eastman is a respected authority in periodontology with experience implementing revolutionary techniques and developing ones of his own, he continually sets and surpasses the bar for periodontal care. A skilled and published periodontist, Dr. Eastman-Craighead received her Doctorate of Dental Medicine Degree and her Professional Certificate in Periodontics from the University of Florida. Dr. Craighead is both a periodontist and a prosthodontist, a feat rarely accomplished by clinicians across the country. The team at Eastman Periodontics and Implants blend the latest, minimally invasive technology with an honest approach to care. To learn more about these doctors, the services they offer, or their cutting-edge practice, visit http://www.eastmanonline.com or call 941-792-3899 for the Bradenton location or 941-351-3000 for the Lakewood Ranch location for a personalized consultation.

Share article on social media or email:

Sean Doherty, MD, named among the best Boston plastic surgeons by Three Best Rated


News Image

Sean Doherty, MD, was recently awarded the distinction of being included in Three Best Rated’s top 3 plastic surgeons in Boston. The website awards the rating after a meticulous 50-point inspection. The selection process considers factors such as the surgeons’ history, patient reviews, complaints, and satisfaction. It also takes into account treatment cost, consumer trust, ratings received from other sources, and general excellence.

Three Best Rated is a trusted review website that conducts rigorous evaluations to identify the highest-quality businesses throughout the United States. The review service has positioned itself as an authority in distinguishing quality over quantity and its awards are trusted by its thousands of readers.

Dr. Doherty currently provides his expert services in plastic surgery of the face and body at the Boston Center for Facial Rejuvenation on Newbury St. in Boston and in Brookline, Mass. He also works with Cynosure in Westford, MA, as Medical Director and Principal Investigator. Other than his day-to-day interactions with patients, Dr. Sean Doherty stays on the cutting edge of the plastic surgery and dermatology fields.

His current professional engagements are rounded out by a collaboration with innovative pharmaceutical company Allergan. Top research and product development occur at the Irish-domiciled biotech company which places emphasis on dermatological, gastroenterological, and eye care products. There, Dr. Doherty offers his expertise as a speaker, trainer, and peer-to-peer educator.

The selection by Three Best Rated is a continuation of a long string of awards and recognition by top publications and authorities. The American Board of Plastic Surgeons board-certified doctor has built a tradition of excellence that cannot be overlooked.

Most recent awards include Top Doctor of plastic surgery in 2020, 2019 and 2017 by Boston Magazine. In 2017, Dr. Doherty made the RealSelf Top 100 while also being inducted into the cosmetic surgery reviewer’s Hall of Fame. Other honors include 2012, 2013, 2015 and 2016 Patients’ Choice awards by Vitals. The list continues with recognition from Castle Connolly, Top 3 Plastic Surgeons, and America’s Best Physicians.

Three Best Rated notes Dr. Sean Doherty’s extensive experience in cutting-edge reconstructive and cosmetic procedures. The rating authority cites Dr. Doherty’s affiliation with Emerson Hospital, St. Elizabeth’s Medical Center, Beth Israel Deaconess-Needham Medical Center, and Mass Eye and Ear Infirmary.

Sean Doherty, MD, is an award-winning plastic surgeon in Boston, MA who treats both men and women on their face and bodies. Receiving board certification in 2010, Dr. Doherty is recognized by peers and patients for his expertise in both surgical and non-surgical procedures.

###

If you would like more information on Dr. Doherty’s services, please fill out the contact form on his website where you can ask about specific procedures of interest. On the contact page, you can find patient paperwork and HIPAA documents ready to download. You can also click through to view before and after photos of procedures as well as read patient testimonials. Alternatively, you can call Dr. Doherty’s Boston office at (617) 935.0801 or his Brookline office at (617) 996.7604.

Share article on social media or email:

Dr. Harvey V. Fineberg to Deliver Keynote on COVID-19 and Public Policy at ASNC2020 Virtual Scientific Session and Exhibition


www.asnc.org/asnc2020

American Society of Nuclear Cardiology (ASNC)

“ASNC has made a concerted effort to assemble the latest recommendations to help the nuclear cardiology community address the challenges of providing patient care in these unprecedented circumstances,” says Sharmila Dorbala, MD, ASNC president. “ASNC2020 will provide a forum to engage attendees.”

Harvey V. Fineberg, MD, PhD, chair of the National Academies’ Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats, will present “Public Policy Decision-making During the COVID-19 Pandemic” during a special session at the American Society of Nuclear Cardiology 2020 Virtual Scientific Session.

ASNC2020 will include more than 40 sessions delivered in a variety of formats between Sept. 9 and Oct. 7. The ASNC2020 virtual live program will convene Sept. 25-26.

Dr. Fineberg coauthored, The Epidemic That Never Was: Policy-Making and the Swine Flu Scare. He is president of the Gordon and Betty Moore Foundation and board chair of the Science Philanthropy Alliance. He previously served as president of the Institute of Medicine, provost of Harvard University, and Dean of the Harvard Chan School of Public Health.

Dr. Fineberg will deliver his keynote during the ASNC2020 session “COVID-19: Public Policy Update and Best Practices for Nuclear Cardiology” on Saturday, Sept. 26, at 10:30 AM (ET). This session is among several at ASNC2020 addressing cardiovascular care during the COVID-19 public health emergency.

“Quality patient care has always been the first and foremost priority for ASNC members,” says Sharmila Dorbala, MD, MPH, FASNC, ASNC president and director of nuclear cardiology at Brigham and Women’s Hospital in Boston. “Since the onset of the pandemic, ASNC has made a concerted effort to assemble the latest information and recommendations to help the nuclear cardiology community address the challenges of providing patient care in these unprecedented circumstances. ASNC2020 will provide a forum to share this information and engage in thoughtful discourse with attendees.”

ASNC2020 will deliver the latest updates across the fields of nuclear cardiology and molecular imaging with a focus on “Using Technology to Improve Patient Care.”

“We have a vision for ASNC2020,” says Terrence Ruddy, MD, FASNC, chair of the ASNC2020 Program Committee and director of nuclear cardiology at the University of Ottawa Heart Institute. “We’ll show you how technology can improve your practice. Nuclear Cardiology and PET are digital technologies. If we were standardized a bit more and aware of all the available technology, we could do much more.”

Dr. Ruddy and Co-chair Piotr Slomka, PhD, of Cedars-Sinai Medical Center have assembled a robust program that delivers on this theme highlighted by these sessions:

COVID-19 and CT Imaging

Friday, Sept. 25, 2020 12:00pm – 1:00pm (ET)

Featuring “COVID-19 Pneumonitis and CT,” presented by H. Henry Guo, MD, PhD, clinical associate professor of radiology at Stanford University.

Cardiac Applications of Artificial Intelligence Approaches in Wearable Devices

Friday, September 25, 2020 2:00pm – 3:00pm (ET)

Featuring “Watch App Identifies Clinically Important Arrhythmias Other Than Atrial Fibrillation” presented by Mintu Turakhia, MD, MAS, associate professor of medicine at Stanford University; director of the Stanford Center for Digital Health; and director of electrophysiology at the Palo Alto Veterans Affairs Health Care System.

Mario Verani Lecture and Keynote Presentation

Friday, September 25, 2020 5:00pm – 6:30pm (ET)

Featuring keynote “Clinical Applications of Artificial Intelligence in Nuclear Cardiology,” presented by Ernest V. Garcia, PhD, MASNC, professor of radiology at Emory University School of Medicine.

Featuring Verani Lecture “The Evolving Role of Nuclear Cardiology in CAD Management in the Era of Multimodality Imaging,” presented by Marcelo Di Carli, MD, MASNC. Dr. Di Carli is chief of nuclear medicine and molecular imaging and director of the cardiovascular imaging program at Brigham and Women’s Hospital and professor of radiology and medicine at Harvard Medical School.

ASNC2020 will also feature, “Diversity and Inclusion in Clinical Nuclear Cardiology – A Case-Based Ethics Session,” moderated by Ola (Olakunle) Akinboboye, MD, MBA, FACC, MPH, FACP, chairman of the Cardiovascular Disease Board at American Board of Internal Medicine and Andrew J. Einstein, MD, PhD, associate professor at Columbia University Medical Center. This will be a joint session with the Association of Black Cardiologists on Friday, September 25, 2020 from 2:00pm – 3:00pm (ET).

ASNC2020 sessions will be delivered in a variety of session formats, including virtual live and pre-recorded on-demand. To register to attend ASNC2020 educational sessions as a member of the press or to arrange interviews with ASNC2020 speakers or other experts, contact Jennifer Taylor Howell, Director of Marketing, at jhowell@asnc.org.

For the latest discussions and updates, refer to official meeting hashtag on social media: #ASNC2020

About the American Society of Nuclear Cardiology

For over 25 years, the American Society of Nuclear Cardiology and its more than 4,300 members have been improving cardiovascular outcomes through image-guided patient management. As the only society dedicated solely to the field of nuclear cardiology, ASNC establishes standards for excellence in cardiovascular imaging through the development of clinical guidelines, professional medical education, advocacy and research development. ASNC provides peer-reviewed original articles through its Journal of Nuclear Cardiology and operates the nation’s first noninvasive cardiac imaging registry, ImageGuide Registry®, to benchmark quality and improve patient care. For more information, visit ASNC.org and follow us on Twitter @MyASNC.



NaviMed Capital Announces Expansion of Investment and Operations Teams


As we grow our firm and find new platform investment opportunities in fast-growing lower middle-market healthcare companies, all of us at NaviMed are very excited to be expanding our team with such high quality and experienced professionals.

NaviMed Capital, a leading healthcare-focused private equity firm based in Washington, DC, today announced the expansion of its team with the addition of two experienced investment professionals as well as an accomplished CFO/CCO.


  • Josh Boylan – Vice President


Mr. Boylan joins NaviMed Capital with more than five years of healthcare private equity investing experience at several well-regarded firms. At NaviMed he will focus on expanding the firm’s investment activity in hospital products, as well as contract development, manufacturing and distribution companies serving the healthcare industry.

At his prior private equity firms, Mr. Boylan was integrally involved in investments in contract manufacturing, pharmaceutical manufacturing and distribution, and hospital products.

Earlier in his career, Mr. Boylan served in the United States Senate as an Economic Policy Fellow focused on Medicare and Medicaid reform. In addition, Mr. Boylan has global healthcare investment banking experience.

Mr. Boylan earned a BS in Economic History from the London School of Economics and Political Science, where he graduated with first class honours.

  • Henry Oelsner – Associate


Mr. Oelsner has several years of private equity and transaction advisory experience. Prior to joining NaviMed Capital, Mr. Oelsner spent two years at a growth-oriented private equity firm focused on investing in leading healthcare, software, and tech-enabled services companies. As part of that role, Mr. Oelsner focused on the firm’s investments in healthcare IT and played an integral role in the acquisitions of several platform investments.

Mr. Oelsner started his career in investment banking where he completed sell-side advisory transactions for growth-focused companies across a range of industry sectors.

Mr. Oelsner graduated with distinction from the University of Virginia’s McIntire School of Commerce, receiving a BS in Commerce with dual concentrations in Finance and Accounting.


Mr. Macklin has more than 20 year of experience in the private equity industry, principally as a Chief Financial Officer and Chief Compliance Officer. At NaviMed, Mr. Macklin oversees critical operational areas including finance and accounting, investor reporting, and regulatory compliance.

Mr. Macklin’s industry experience includes senior financial roles at several leading private equity firms with aggregate assets under management in excess of $2 billion. Mr. Macklin started his career in public accounting and also has held positions at asset management and investment firms.

Mr. Macklin is a Certified Public Accountant (inactive) and a Chartered Financial Analyst (active). He holds a BS in Mathematics from the College of William and Mary and an MBA from the Wharton School of the University of Pennsylvania.

These three additions join NaviMed’s senior investment team that has a track record of value creation spanning, in the aggregate, dozens of investments and more than $11 billion of enterprise value created over the course of their collective careers, with decades of combined healthcare investing and operating experience.

“As we grow our firm and find new platform investment opportunities in fast-growing lower middle-market healthcare companies, all of us at NaviMed are very excited to be expanding our team with such high quality and experienced professionals,” said Bijan Salehizadeh, Managing Director of NaviMed Capital.

“We believe that the global coronavirus pandemic will increase the already robust demand dynamics in the hospital products industry. We are very pleased to add a professional with Josh’s sector experience as we expand our efforts to target this large opportunity,” said Ryan Schwarz, Managing Director of NaviMed Capital.

“As NaviMed grows, so does the intensity of limited partner relations, financial management and compliance matters. We feel fortunate to be joined by Rodd, who is one of the most experienced private equity CFO/CCOs in the Washington DC region,” said Brian Canann, Managing Director of NaviMed Capital.

About NaviMed Capital

NaviMed Capital is a Washington, DC-based private capital firm focused exclusively on the healthcare industry. NaviMed makes investments in fast growing lower middle-market healthcare businesses. The firm focuses on healthcare services, healthcare IT, hospital products and pharmaceutical services businesses which NaviMed believes are poised to benefit from the reform and technology innovation forces reshaping the healthcare industry. NaviMed targets profitable private companies with up to $10 million of EBITDA and double digit revenue growth. NaviMed seeks investments which it believes can benefit from its deep industry expertise, broad relationship network and the track record of success of its senior investment professionals as healthcare investors and operators. NaviMed’s senior investment team has a track record of value creation spanning, in the aggregate, dozens of investments and more than $11 billion of enterprise value created over the course of their combined careers.

For more information, please visit http://www.navimed.com.

Share article on social media or email:

Software Helping Improve Healthcare Infrastructure Showcased On “Viewpoint” With Dennis Quaid


News Image

“Viewpoint” will provide additional details about the new software that is helping to enhance healthcare infrastructure on the impending episode.

Dennis Quaid, typically recognized for his roles in films like “Frequency” and “Wyatt Earp,” is presently putting his skills to use hosting television’s “Viewpoint”. The informative program features respective field experts who discuss a large variety of subjects that affect people of all demographics. Coming to the show is an episode highlighting the latest software that is aiding the infrastructure of healthcare.

Computers are one of the modern world’s most benefited from technological advancements. The average person utilizes the computer daily to socialize, shop, bank, organize, and research. Most businesses in today’s world use computers to efficiently store company and client information, and the healthcare industry is no different.

More healthcare companies are adopting electronic record-keeping practices by way of software. With health records being available electronically, patients are able more easily access their info. Computerized records make transferring to new or referred physicians effortless, too. Some patients may fear security breaches with electronic records, but technological advancements in software have led to safer protection against personal information leaks.

Electronic data keeping is more secure and less of a hassle compared to its paper counterparts. “Viewpoint” will provide additional details about the new software that is helping to enhance healthcare infrastructure on the impending episode.

“Viewpoint” with Dennis Quaid is carefully reviewed before broadcast. The educational segment has accepted multiple Tellys for its efforts in the television arena.

Share article on social media or email:

NeoTract Designates Dr. David Moore as UroLift® Center of Excellence


News Image

“Dr. David Moore has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that David Moore, M.D., Deaconess Urology in Newburgh, IN, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Moore has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“Dr. David Moore has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit.

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

LifeCare Experiencing Unprecedented Live Webinar Demand From Members Nationwide Due To COVID-19


LifeCare

LifeCare

With our live webinars, we’re helping employees stay productive by delivering solutions in the most relevant, efficient ways possible – in this case, through in-demand use of live video streaming.

As workers across the country continue to adapt to remote work environments due to the COVID-19 epidemic, LifeCare, Inc – an industry leading Work-Life provider – is answering a dramatic spike in demand for their comprehensive selection of live educational webinars.

“We see the video streaming and collaboration trend booming everywhere with Zoom and the like,” explains Peter Burki, Co-Founder & CEO of LifeCare, “so it’s not surprising members are tuning in by the tens of thousands to experience our exceptional digital learning sessions, and we’re only too happy to help.”

Specifically, the number of live webinars presented to members from April through mid-July of 2020 was up by almost 200% over the same period in 2019. Prior to the pandemic, members highly utilized live, in-person training provided by LifeCare. So, as businesses across the country shifted to embrace digital collaboration platforms, LifeCare was prepared, empowering their client’s employees with interactive, video-based webinars targeting the COVID-19 pandemic.

As demand continues to rise, LifeCare has scaled up both the number and frequency of their webinars to maximize member engagement. In fact, LifeCare created more than two dozen new webinars focused on the unique challenges of living and working during a nationwide pandemic such as this. These are all in addition to LifeCare’s growing catalog of over 250 webinars, featuring personal assistance topics across parenting, senior assistance, professional development and much more.

The webinars are managed by LifeCare’s Educational Services team. Each production features valuable insights and strategies from industry experts, category specialists and guest speakers across a myriad of life event topics. LifeCare has over 61,000 clients across industries like government, education, healthcare, automotive, entertainment and insurance. These webinars are carefully created to be relevantly helpful to all, no matter what life challenges the client’s employees might be facing.

Across all webinars, the greatest demand has been for topics related to emotional health and well-being. These include “strength & resiliency”, “coping with change”, “relaxation techniques”, “fostering inclusion”, and “coping with stress”, among others. The soaring interest in these subjects clearly demonstrates the emotional and psychological assistance desired by workforces everywhere, especially when delivered via live video.

The reactions from both LifeCare clients and members has been overwhelmingly positive:

  • “These webinars have been essential to my peace of mind during this pandemic. I could not have gotten through without them.” – LifeCare Member
  • “This session was AWESOME! It was extremely well-organized, the presenter offered excellent and helpful insights and information and I left with a glow of satisfaction of attending the webinar. Thanks for doing such a wonderful job with this!” – LifeCare Member
  • “Wonderful presentation and presenter! I believe that we can all benefit from learning some ways to reduce stress, especially during this pandemic. Thank you!” – LifeCare Client


LifeCare ensures the highest quality webinars by conducting attendee surveys after each and every event. During this time of unprecedented growth, LifeCare has maintained a 99% satisfaction rate among all webinar attendees. In addition, understanding that members may not always be able to attend live webinars, LifeCare provides an on-line webinar library of prior events.

“Our members are experiencing unexpected challenges and stress during this unique time,” continues Mr. Burki. “With our live webinars, we’re helping employees stay productive by delivering solutions in the most relevant, efficient ways possible – in this case, through in-demand use of live video streaming.”

About LifeCare

LifeCare provides employer-sponsored work-life benefits to 61,000 clients, including Fortune 500 companies and large branches of the federal government, representing 100 million members nationwide. LifeCare offers a full suite of solutions that save members time with personal life needs such as Backup Care Connection, Senior Care Management, Homework Connection, Mothers@Work, MilkShip, LeaveCoach, and BenConnect. LifeCare also operates LifeMart, an online discount shopping website that provides real savings on everyday products and needs. LifeCare is headquartered in Shelton, CT, and can be followed on Linkedin.

Share article on social media or email:

The iaedp™ Foundation Extends Deadline for Proposals for 2021 Symposium to September 8, 2020


“As the industry evolves in light of current events, there has never been a more important time to come together, share information and continue dialogue,” said Bonnie Harken, Managing Director at iaedp™.

The International Association of Eating Disorders Professionals Foundation (iaedp™) is extending its final close date for proposals for the annual iaedp™ Symposium slated for February 17 – 21, 2021. The new deadline for all 2021 proposals is September 8, 2020. The call is open online at https://iaedp.confex.com/iaedp/2021/cfp.cgi.

The Spanish-Language Call for Proposals also is online at https://iaedp.confex.com/iaedp/2021/spanish/cfp.cgi and open through September 8, 2020.

Next year’s iaedp™ Symposium will be held at the JW Marriott Desert Springs Resort & Spa. More information about the 2021 iaedp™ Symposium can be found at https://iaedp.confex.com/iaedp/2021/cfp.cgi.

Each year, the iaedp™ Symposium program is created by professionals who work in therapeutic settings with patients. Their objective is to provide an exciting, quality program.

“As the industry evolves in light of current events, there has never been a more important time to come together, share information and continue dialogue,” said Bonnie Harken, Managing Director at iaedp™. “We’d like to invite our members to be a part of the process. To find out more about participation, additional information is available online.”

The iaedp™ Foundation is pursuing abstracts in both English and Spanish on inventive and inclusive treatment modalities for the many phases of the journey for those with eating disorders — from denial and resistance to treatment and ultimately recovery. The group also requests treatment providers from all disciplines to convert their latest or ongoing research and treatment updates into meaningful eating disorder treatment protocols across populations.

Many of the professionals who submit proposals for the iaedp™ Symposium include experiential or interactive components in their presentations.

About the iaedp™ Foundation: Since 1985, the International Association of Eating Disorders Professionals has provided education and training standards to an international and multidisciplinary group of various healthcare treatment providers and helping professions.

MemberSHARE.iaedp.com is an iaedp™ business journal and online member resource to learn about noteworthy member achievements, continuing education webinars and U.S. and international chapter activity and events; for more information, visit MemberSHARE.

The Presidents Council provides iaedp™ support and includes: Center for Change; Center for Hope of the Sierras; Center for Discovery; Eating Recovery Center; Willow Place; Laureate Eating Disorders Program; The Meadows Ranch; Rogers Behavioral Health; Rosewood Centers for Eating Disorders; Selah House; The Renfrew Center; Veritas Collaborative; Alsana Eating Disorder Treatment & Recovery Centers; Walden Behavioral Care and KIPU.

Share article on social media or email: